SequelSEC

Medtronic plc MDT

Electromedical & Electrotherapeutic Apparatus · CIK 0001613103 · Fiscal year ends 0424

Revenue
$37.54B
Fiscal year ended 2026-07-31
Operating income
$6.79B
Fiscal year ended 2026-07-31
Free cash flow
$6.13B
Fiscal year ended 2026-07-31

Medtronic plc (MDT) reported revenue of $37.54B and net income of $5.23B for the fiscal year ended 2026-07-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Medtronic plc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.

Income

Medtronic plc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Revenue$37.54B
Cost of revenue$13.14B
Gross profit$24.40B
Operating income$6.79B
Net income$5.23B
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$6.60B
Income tax expense$1.33B
Diluted EPSUnavailable
Selling, general & administrative$12.18B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Medtronic plc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Cash & equivalents$1.69B
Total assets$93.31B
Current assets$24.39B
Total liabilities$42.46B
Current liabilities$11.80B
Total equity incl. NCI$50.85B
Temporary (mezzanine) equityUnavailable
Inventory$6.22B
Accounts receivable$6.36B
Goodwill$43.19B
Long-term debt$25.62B
Accounts payable$2.70B

Cash flow

Medtronic plc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Operating cash flow$8.04B
Capital expenditures$1.90B
Investing cash flow-$3.83B
Financing cash flow-$3.71B
Net change in cash$418.00M
Stock-based compensation$496.00M
Common dividends paid$3.65B
Common share repurchases$1.18B
Depreciation & amortization$2.94B

Derived

Medtronic plc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-31
Free cash flow$6.13B
Gross margin65.0%
Operating margin18.1%
FCF margin16.3%
SBC / revenue1.3%
Current ratio2.07x
Revenue YoY growth9.8%
Net margin13.9%
R&D / revenueUnavailable
CapEx / revenue5.1%
Long-term debt / equity0.50x
Effective tax rate20.2%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MDT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-09-03View SEC filing
10-K · Filed 2026-06-18View SEC filing
10-Q · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-11-25View SEC filing
10-Q · Filed 2025-08-26View SEC filing
10-K · Filed 2025-06-20View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.